Acrivon

Acrivon is a biotechnology company developing targeted therapies to improve the lives of patients. Headquartered in the United States, Acrivon is leveraging its proprietary proteomics-based patient selection approach to match drug mechanisms to the biological drivers of cancer, with the goal of delivering better outcomes for patients suffering from common and pressing cancer types.